Vildagliptin/Metformin HCl Merck 50mg/1000mg film-coated Tablets Malta - English - Medicines Authority

vildagliptin/metformin hcl merck 50mg/1000mg film-coated tablets

merck healthcare kgaa frankfurter strasse 250, 64293 darmstadt, germany - vildagliptin, metformin hydrochloride - film-coated tablet - vildagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes

Sitagliptin/Metformin hydrochloride Tiefenbacher 50/850 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin hydrochloride tiefenbacher 50/850 mg film-coated tablets

alfred e. tiefembacher (gmbh &co. kg) van-der-smissen-straße 1, 22767 hamburg, germany - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Sitagliptin/Metformin hydrochloride Tiefenbacher 50/1000 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin hydrochloride tiefenbacher 50/1000 mg film-coated tablets

alfred e. tiefembacher (gmbh &co. kg) van-der-smissen-straße 1, 22767 hamburg, germany - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes

Sitagliptin/Metformin Rafarm 50 mg/1000 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin rafarm 50 mg/1000 mg film-coated tablets

rafarm s.a. 12, korinthou str., 15451 neo psihiko, athens, greece - sitagliptin, methionine - film-coated tablet - sitagliptin 50 mg methionine 1000 mg - drugs used in diabetes

Linagliptin/Metformin Sandoz 2.5 mg/500 mg film-coated tablets Malta - English - Medicines Authority

linagliptin/metformin sandoz 2.5 mg/500 mg film-coated tablets

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - film-coated tablet - linagliptin 2.5 mg metformin hydrochloride 500 mg - drugs used in diabetes

Linagliptin/Metformin Sandoz 2.5 mg/1000 mg film-coated tablets Malta - English - Medicines Authority

linagliptin/metformin sandoz 2.5 mg/1000 mg film-coated tablets

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - film-coated tablet - linagliptin 2.5 mg metformin hydrochloride 1000 mg - drugs used in diabetes

Sitagliptin/Metformin Clonmel 50 mg/1000 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

sitagliptin/metformin clonmel 50 mg/1000 mg film-coated tablets

clonmel healthcare ltd - sitagliptin; metformin hydrochloride - film-coated tablet - 50 mg/1000 milligram(s) - metformin and sitagliptin

Sitagliptin/Metformin Clonmel 50 mg/850 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

sitagliptin/metformin clonmel 50 mg/850 mg film-coated tablets

clonmel healthcare ltd - sitagliptin; metformin hydrochloride - film-coated tablet - 50 mg/850 milligram(s) - metformin and sitagliptin

Glyformin 500mg film-coated Tablets Malta - English - Medicines Authority

glyformin 500mg film-coated tablets

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - metformin hydrochloride - film-coated tablet - metformin hydrochloride 500 mg - drugs used in diabetes

VIPDOMET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

vipdomet 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack

takeda pharmaceuticals australia pty ltd - metformin hydrochloride, quantity: 1000 mg; alogliptin benzoate, quantity: 17 mg (equivalent: alogliptin, qty 12.5 mg) - tablet, film coated - excipient ingredients: mannitol; purified talc; iron oxide yellow; povidone; microcrystalline cellulose; magnesium stearate; titanium dioxide; crospovidone; hypromellose - vipdomet is indicated to improve glycaemic control in adult patients (> or = 18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control and treatment with both alogliptin and metformin is appropriate,,- when treatment with metformin alone does not provide adequate control; or - in combination with a thiazolidinedione or with insulin, when dual therapy does not provide adequate control.,vipdomet can also be used to replace separate tablets of alogliptin and metformin in patients already being treated with this combination.